Showing results (261-270 of 289) with videos related to

Sort By:
Pageof 29
Facial Plastic Surgery & Aesthetic Medicine|January 17, 2023
Association of Head and Neck Anatomic Zones with Microvascular Reconstruction OutcomesEmma De Ravin, Louis-Xavier Barrette, Ryan M Carey, et al.
The Laryngoscope|June 2, 2021
Locoregional Recurrence in p16-Positive Oropharyngeal Squamous Cell Carcinoma After TORSRyan M Carey, Robert M Brody, David Shimunov, et al.
Annals of Clinical and Translational Neurology|March 7, 2025
Calcium modulating ligand confers risk for Parkinson's disease and impacts lysosomesHanwen Zhang, Daniel Kargilis, Thomas Tropea, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 29, 2020
Oncologic Outcomes Following Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Carcinoma in Older PatientsHarman S Parhar, David Shimunov, Jason G Newman, et al.
Eneuro|March 30, 2016
Ablation of Type-1 IFN Signaling in Hematopoietic Cells Confers Protection Following Traumatic Brain InjuryIla P Karve, Moses Zhang, Mark Habgood, et al.
Journal of Neurological Surgery. Part B, Skull Base|February 9, 2019
Sinonasal Undifferentiated Carcinoma: A 15-Year Single Institution ExperienceAlan D Workman, Robert M Brody, Edward C Kuan, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Secreted GPNMB enhances uptake of fibrillar alpha-synuclein in a non-cell-autonomous process that can be blocked by anti-GPNMB antibodiesMarc Carceles-Cordon, Eliza M Brody, Masen L Boucher, et al.
Neuron|May 13, 2026
Secreted GPNMB enhances uptake of fibrillar alpha-synuclein in a non-cell-autonomous process that can be blocked by anti-GPNMB antibodiesMarc Carceles-Cordon, Eliza M Brody, Masen L Boucher, et al.
The Laryngoscope|August 13, 2025
Outcomes of HPV+ Oropharyngeal Carcinoma of Unknown Primary Following Transoral Robotic SurgeryTheodore A Gobillot, Gregory Weinstein, Austin Cao, et al.
Head & Neck|December 16, 2020
Increased rate of recurrence and high rate of salvage in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma with adverse features treated with primary surgery without recommended adjuvant therapyRyan M Carey, David Shimunov, Gregory S Weinstein, et al.
Pageof 29